Screener
Iovance Biotherapeutics, Inc. IOVA Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
FAQ
- What is Iovance Biotherapeutics, Inc.'s operating margin?
- Iovance Biotherapeutics, Inc. (IOVA) reported operating margin of -92.7% in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s operating margin changed year-over-year?
- Iovance Biotherapeutics, Inc.'s operating margin increased by 45.5% year-over-year, from -170% to -92.7%.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s operating margin?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s operating margin has grown at a -93.7% compound annual growth rate (CAGR), from -38,735% to -153.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Iovance Biotherapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude